Cargando…
Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?
[Image: see text] The solid form landscape of 5-HT2a antagonist 3-(4-(benzo[d]isoxazole-3-yl)piperazin-1-yl)-2,2-dimethylpropanoic acid hydrochloride (B5HCl) proved difficult to establish. Many crystalline materials were produced by solid form screening, but few forms readily grew high quality cryst...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629560/ https://www.ncbi.nlm.nih.gov/pubmed/29018305 http://dx.doi.org/10.1021/acs.cgd.7b00842 |
_version_ | 1783269067371577344 |
---|---|
author | Braun, Doris E. Lingireddy, Sreenivas R. Beidelschies, Mark D. Guo, Rui Müller, Peter Price, Sarah L. Reutzel-Edens, Susan M. |
author_facet | Braun, Doris E. Lingireddy, Sreenivas R. Beidelschies, Mark D. Guo, Rui Müller, Peter Price, Sarah L. Reutzel-Edens, Susan M. |
author_sort | Braun, Doris E. |
collection | PubMed |
description | [Image: see text] The solid form landscape of 5-HT2a antagonist 3-(4-(benzo[d]isoxazole-3-yl)piperazin-1-yl)-2,2-dimethylpropanoic acid hydrochloride (B5HCl) proved difficult to establish. Many crystalline materials were produced by solid form screening, but few forms readily grew high quality crystals to afford a clear picture or understanding of the solid form landscape. Careful control of crystallization conditions, a range of experimental methods, computational modeling of solvate structures, and crystal structure prediction were required to see potential arrangements of the salt in its crystal forms. Structural diversity in the solid form landscape of B5HCl was apparent in the layer structures for the anhydrate polymorphs (Forms I and II), dihydrate and a family of solvates with alcohols. The alcohol solvates, which provided a distinct packing from the neat forms and the dihydrate, form layers with conserved hydrogen bonding between B5HCl and the solvent, as well as stacking of the aromatic rings. The ability of the alcohol hydrocarbon moieties to efficiently pack between the layers accounted for the difficulty in growing some solvate crystals and the inability of other solvates to crystallize altogether. Through a combination of experiment and computation, the crystallization problems, form stability, and desolvation pathways of B5HCl have been rationalized at a molecular level. |
format | Online Article Text |
id | pubmed-5629560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-56295602017-10-08 Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few? Braun, Doris E. Lingireddy, Sreenivas R. Beidelschies, Mark D. Guo, Rui Müller, Peter Price, Sarah L. Reutzel-Edens, Susan M. Cryst Growth Des [Image: see text] The solid form landscape of 5-HT2a antagonist 3-(4-(benzo[d]isoxazole-3-yl)piperazin-1-yl)-2,2-dimethylpropanoic acid hydrochloride (B5HCl) proved difficult to establish. Many crystalline materials were produced by solid form screening, but few forms readily grew high quality crystals to afford a clear picture or understanding of the solid form landscape. Careful control of crystallization conditions, a range of experimental methods, computational modeling of solvate structures, and crystal structure prediction were required to see potential arrangements of the salt in its crystal forms. Structural diversity in the solid form landscape of B5HCl was apparent in the layer structures for the anhydrate polymorphs (Forms I and II), dihydrate and a family of solvates with alcohols. The alcohol solvates, which provided a distinct packing from the neat forms and the dihydrate, form layers with conserved hydrogen bonding between B5HCl and the solvent, as well as stacking of the aromatic rings. The ability of the alcohol hydrocarbon moieties to efficiently pack between the layers accounted for the difficulty in growing some solvate crystals and the inability of other solvates to crystallize altogether. Through a combination of experiment and computation, the crystallization problems, form stability, and desolvation pathways of B5HCl have been rationalized at a molecular level. American Chemical Society 2017-09-07 2017-10-04 /pmc/articles/PMC5629560/ /pubmed/29018305 http://dx.doi.org/10.1021/acs.cgd.7b00842 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. |
spellingShingle | Braun, Doris E. Lingireddy, Sreenivas R. Beidelschies, Mark D. Guo, Rui Müller, Peter Price, Sarah L. Reutzel-Edens, Susan M. Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few? |
title | Unraveling Complexity in the Solid Form Screening
of a Pharmaceutical Salt: Why so Many Forms? Why so Few? |
title_full | Unraveling Complexity in the Solid Form Screening
of a Pharmaceutical Salt: Why so Many Forms? Why so Few? |
title_fullStr | Unraveling Complexity in the Solid Form Screening
of a Pharmaceutical Salt: Why so Many Forms? Why so Few? |
title_full_unstemmed | Unraveling Complexity in the Solid Form Screening
of a Pharmaceutical Salt: Why so Many Forms? Why so Few? |
title_short | Unraveling Complexity in the Solid Form Screening
of a Pharmaceutical Salt: Why so Many Forms? Why so Few? |
title_sort | unraveling complexity in the solid form screening
of a pharmaceutical salt: why so many forms? why so few? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629560/ https://www.ncbi.nlm.nih.gov/pubmed/29018305 http://dx.doi.org/10.1021/acs.cgd.7b00842 |
work_keys_str_mv | AT braundorise unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew AT lingireddysreenivasr unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew AT beidelschiesmarkd unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew AT guorui unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew AT mullerpeter unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew AT pricesarahl unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew AT reutzeledenssusanm unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew |